Compare · head to head
Ceribell vs NeuroPace
Ceribell ranks higher overall — 360 rank 37 vs 30.
NeuroPace leads on Quality (44 vs 28). Ceribell leads on Growth (61 vs 52) and Safety (48 vs 31). The two are close on Value and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| Size | Small | Small |
| ISIN | US15678C1027 | US6412881053 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 37 | 30 |
| Value | 39 | 40 |
| Quality | 28 | 44 |
| Growth | 61 | 52 |
| Safety | 48 | 31 |
| Sentiment | 60 | 61 |
| Quality details | ||
| Profitability | 30 | 32 |
| Cash Truth | 25 | 55 |
Ceribell vs GE HealthcareCeribell vs Integra LifeSciencesCeribell vs HyperfineCeribell vs InogenAdd a third stock →
Full analyses: Ceribell · NeuroPace
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100